Results 141 to 150 of about 51,320 (261)

What Is Your Diagnosis? Superficial Cervical Lymph Node Cytology

Veterinary Clinical Pathology, EarlyView.
Vinicius N. Hirata, Rúbia S. da Silva, Francisca B. Lang, Augusto de Oliveira, Cinthia M. de Andrade   +4 more
wiley   +1 more source

Integrative Multi‐Omics Analysis Elucidates the Progressive Disease Landscape and Reveals Dynamic Protein Biomarkers for MASLD Surveillance

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Integrated transcriptomic, single‐cell, pseudotime, cell–cell communication, human tissue, and in vivo analyses define a dynamic four‐gene axis across the MASLD continuum. Progressive CYP2C19 downregulation and AKR1B10, COL1A2, and SPP1 upregulation link metabolic dysfunction to disease progression, while AKR1B10 knockdown or CYP2C19 overexpression ...
Kejun Liu, Bozhi Zhang, Yezhen Tang, Zhenyao Tan, Yang Bu, Yongxue Lv   +5 more
wiley   +1 more source

Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma. [PDF]

Discov Oncol
Ökten IN, Baydaş T.
europepmc   +1 more source

Liraglutide and calcitonin [PDF]

Journal of Diabetes, 2010
openaire   +2 more sources

Lipid Dynamics in the Amyloid Cascade Hypothesis: Evaluating the Biological Relevance of In Vitro Models

ChemBioChem, Volume 27, Issue 11, 15 June 2026.
This review reconsiders the amyloid cascade by placing lipid dynamics at its core. It shows that free lipids, governed by critical micellar concentration, act as pathological chaperones that redirect amyloid aggregation toward membrane‐damaging species.
Sofia Serravalle, Fabio Lolicato, Carmelo Tempra, Martina Pannuzzo, Michele F. M. Sciacca, Danilo Milardi, Carmelo La Rosa   +6 more
wiley   +1 more source

Outcomes of surgical, medication and combination therapies for cherubism: a systematic review and qualitative analysis. [PDF]

Front Oral Health
Julia V, Sulistyani LD, Aryyaguna D, Nuita R, Shinta Maharani E, Purnomo J, Ariawan D, Latief MA, Utomo YA, Ratman MF, Nakamura N.   +10 more
europepmc   +1 more source

Strategies for Loading and Releasing Peptide Therapeutics in Biodegradable Carriers

Advanced Functional Materials, Volume 36, Issue 44, 1 June 2026.
A biodegradable carrier‐based peptide delivery system is a powerful treatment platform for diverse diseases, owing to its superior therapeutic efficacy and low toxicity. This review examines the conventional peptide‐loaded carrier fabrication process and its current limitations.
Wookyoung Jang, Ki Wan Bong
wiley   +1 more source

Calcitonin-secreting pancreatic neuroendocrine tumor: A case report and literature review. [PDF]

J Family Med Prim Care
Wang H, Li J, Wang Z, Hua S, Liao Q.
europepmc   +1 more source

Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea

Chronic Diseases and Translational Medicine, Volume 12, Issue 2, Page 100-112, June 2026.
Cellular and molecular mechanisms of obesity‐related obstructive sleep apnea (OSA). ADMA: asymmetric dimethyrarginine, NLRP3: nucleotide‐binding domain, leucine‐rich repeat family, Pyrin domain containing 3, TLR: toll‐like receptors, IL‐1β: interleukin‐1β, IL‐6: interleukin‐6; LPS: lipopolysacharide, ROS: reactive oxygen species, TNF‐α.
Anish Preshy, Cornelius J. Fernandez, Mohammad Hamid Nedai, Joseph M. Pappachan   +3 more
wiley   +1 more source

Prediction of distant metastases at diagnosis in medullary thyroid cancer: combining calcitonin with lymph node imaging. [PDF]

J Endocr Soc
Schonebaum LE, Razaghi Siahroudi H, Chaker L, van den Berg SAA, van Ginhoven TM, Peeters RP, Visser WE.   +6 more
europepmc   +1 more source